Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
Title:
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
Author:
Farge, Dominique Loisel, Séverine Resche-Rigon, Matthieu Lansiaux, Pauline Colmegna, Ines Langlais, David Charles, Catney Pugnet, Grégory Maria, Alexandre Thibault Jacques Chatelus, Emmanuel Martin, Thierry Hachulla, Eric Kheav, Vissal David Lambert, Nathalie C Wang, HanChen Michonneau, David Martinaud, Christophe Sensebé, Luc Cras, Audrey Tarte, Karin